This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Zacks Initiates Coverage of AMREP With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates AMREP as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore AXR's strategic positioning and financial health amid market challenges.
AXRPositive Net Change
real-estate
Gildan Activewear (GIL) to Post Q2 Earnings: Factors to Note
by Zacks Equity Research
Gildan Activewear's (GIL) concentrated efforts on key product lines, particularly in the activewear segment, are expected to have contributed to top-line growth in the second quarter.
ANFNegative Net Change COSTPositive Net Change GPSPositive Net Change GILNegative Net Change
consumer-discretionary retail
SNAP Gears Up to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
SNAP's second-quarter 2024 results are likely to reflect the steady usage of the Snapchat platform, boosted by growing AI efforts and subscribers.
AAPLPositive Net Change CTSHNegative Net Change ANETPositive Net Change SNAPPositive Net Change
tech-stocks
What to Expect From American Tower (AMT) in Q2 Earnings?
by Zacks Equity Research
American Tower's (AMT) Q2 earnings are likely to have benefited from the solid demand for its communication real estate portfolio, though high interest expenses and elevated churn remain concerns.
AMTNegative Net Change VTRPositive Net Change EXRNegative Net Change
communications finance reit
Vertex (VRTX) Stock Before Q2 Earnings: To Buy or Not to Buy?
by Ahan Chakraborty
Vertex's (VRTX) second-quarter revenues are expected to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
VRTXPositive Net Change MRNANegative Net Change CRSPNegative Net Change
biotechnology biotechs crispr earnings-preview medical pharmaceuticals
Janus Henderson (JHG) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Janus Henderson's (JHG) second-quarter 2024 results are likely to benefit from favorable equity market performance. Yet, a rise in costs is likely to be a spoilsport.
APONegative Net Change JHGNegative Net Change HLNENegative Net Change
finance
What Awaits Biogen (BIIB) in Q2 Earnings Post Leqembi Setback?
by Zacks Equity Research
Biogen's (BIIB) sales in the second quarter are likely to have been hurt by lower sales of its multiple sclerosis drugs, while sales of Spinraza are likely to have been hurt by increased competition.
BIIBPositive Net Change AMGNNegative Net Change AGENPositive Net Change SAGENegative Net Change
biotechs pharmaceuticals
Should You Buy Costamare (CMRE) Stock Ahead of Q2 Earnings?
by Maharathi Basu
As Costamare (CMRE) gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, is it the right time to buy the stock?
FROPositive Net Change CMREPositive Net Change DACPositive Net Change
transportation
Steven Madden (SHOO) Lined Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Steven Madden's (SHOO) focus on international expansion, diversification into accessories and apparel and strengthening DTC channels is likely to have favorably impacted the second-quarter top line.
ANFNegative Net Change COSTPositive Net Change GPSPositive Net Change SHOOPositive Net Change
consumer-discretionary retail
Will High Expenses Hurt Dorian LPG's (LPG) Q1 Earnings?
by Zacks Equity Research
The increased demand for liquefied petroleum gases is likely to have aided Dorian LPG's (LPG) top line in fiscal Q1.
EXPDPositive Net Change CPANegative Net Change LPGNegative Net Change
transportation
Roblox (RBLX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Roblox's (RBLX) second-quarter 2024 performance is expected to have benefited from growth in bookings and daily active users while experiencing margin pressure.
AAPLPositive Net Change ASPNPositive Net Change GDDYPositive Net Change RBLXNegative Net Change
consumer-discretionary
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
by Zacks Equity Research
Haemonetics' (HAE) first-quarter fiscal 2025 results are likely to reflect the benefits of hemostasis management growth.
TEVANegative Net Change HAENegative Net Change PENNegative Net Change HIMSNegative Net Change
earnings medical
Will Prudential (PRU) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to reflect higher spread income, equity market appreciation and growth in indexed variable annuities, partially offset by lower underwriting results.
PRUPositive Net Change FNFNegative Net Change KMPRNegative Net Change OSCRPositive Net Change
insurance
Hershey's (HSY) Q2 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Hershey's (HSY) Q2 results are likely to reflect gains from brand strength, but high commodity costs, increased selling, marketing and administrative expenses and currency volatility are concerns.
PGPositive Net Change HSYNegative Net Change CLXNegative Net Change COTYPositive Net Change
consumer-staples earnings
Microchip (MCHP) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Microchip's (MCHP) first-quarter fiscal 2025 results are likely to suffer from a slowdown in business due to sluggish demand that resulted from a high level of inventory with customers.
AAPLPositive Net Change MCHPPositive Net Change CACIPositive Net Change DOCNPositive Net Change
tech-stocks
Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Dr. Reddy's (RDY) reports mixed first-quarter fiscal 2025 results, wherein earnings lag estimates, but revenues beat the same, driven by growth in global generics sales in North America and India.
RDYPositive Net Change RHHBYNegative Net Change RAPTPositive Net Change ANVSNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Altria's (MO) Q2 Earnings Coming Up: Buy, Sell or Hold Steady?
by Vrishali Bagree
Altria Group's (MO) second-quarter earnings are likely to reflect gains from the company's pricing power and smoke-free product strength amid soft cigarette volumes.
MOPositive Net Change PMPositive Net Change BTIPositive Net Change JAPAYPositive Net Change
consumer-staples earnings-preview tobacco
GoDaddy (GDDY) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
GoDaddy's (GDDY) second-quarter 2024 results are likely to benefit from strong momentum across the Applications & Commerce business and expanding global footprint.
AAPLPositive Net Change CACIPositive Net Change GDDYPositive Net Change DOCNPositive Net Change
tech-stocks
Lumen (LUMN) to Use Microsoft Cloud to Boost Transformation
by Zacks Equity Research
By leveraging Microsoft's Azure, Lumen (LUMN) aims to cut technology costs, eliminate outdated systems and silos, upgrade its services and develop new solutions for its global clients
BMINegative Net Change ANETPositive Net Change ONTOPositive Net Change LUMNPositive Net Change
tech-stocks
Is Coinbase (COIN) a Buy or a Wait-&-See Before Q2 Earnings?
by Tanuka De
Coinbase's (COIN) second-quarter results are likely to benefit from increased volatility, expansion of operations and a growing crypto economy.
ENVNegative Net Change FIPositive Net Change COINNegative Net Change
business-services cryptocurrency earnings-preview
Should Apple (AAPL) Stock be in Your Portfolio Pre-Q3 Earnings?
by Aniruddha Ganguly
Apple's (AAPL) third-quarter fiscal 2024 results are likely to reflect strong services growth despite unfavorable forex and sluggish demand for iPhone in China.
AAPLPositive Net Change MSFTPositive Net Change HPQNegative Net Change DELLNegative Net Change
computers earnings-preview tech-stocks
META Stock Before Q2 Earnings Report: To Buy or Not to Buy?
by Aniruddha Ganguly
META's second-quarter 2024 revenues are expected to reflect the benefits of leveraging AI to boost engagement across its offerings.
GOOGLPositive Net Change SNAPPositive Net Change PINSNegative Net Change METAPositive Net Change
advertising earnings-preview social-media tech-stocks
Will Healthy Product Revenues Boost Arista's (ANET) Q2 Earnings?
by Zacks Equity Research
Arista (ANET) is expected to have earned higher Q2 revenues from its product segment, backed by growing demand for its fixed, modular and distributed Etherlink switching platforms.
AMDPositive Net Change SIMOPositive Net Change ANETPositive Net Change PINSNegative Net Change
communications earnings tech-stocks
Affimed (AFMD) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
On Affimed's (AFMD) second-quarter 2024 earnings call, investors' focus is likely to be on the progress of its pipeline candidates being developed for various cancer indications.
RHHBYNegative Net Change AMGNNegative Net Change AFMDNegative Net Change KRYSNegative Net Change
biotechs
Valaris' (VAL) Jack-Up Rig Mobilized for Selene Well Drilling
by Zacks Equity Research
Valaris' (VAL) jack-up rig is slated to drill the Selene exploration well in the Southern North Sea.
VALNegative Net Change SMNegative Net Change EGYNegative Net Change ETNegative Net Change
energy oil-energy